Product NewsIsraeli Drug Development Companies Are Poised for 505(b)(2) Development Process, Camargo Expert Says
Product NewsVentana Announces HER2 Companion Diagnostic to Identify Breast Cancer Patients for Roche's Latest Targeted Medicines
Product NewsGenomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
Product NewsTrophos Completes Pivotal Phase II/III Study of Olesoxime in Spinal Muscular Atrophy (SMA)